Home / KLK8 Knockout Cell Lines

KLK8 Knockout Cell Lines

Gene: KLK8

Official Full Name: kallikrein related peptidase 8provided by HGNC

Gene Summary: Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in tandem in a gene cluster on chromosome 19. The encoded protein may be involved in proteolytic cascade in the skin and may serve as a biomarker for ovarian cancer. Alternate splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO31078 KLK8 Knockout cell line (HCT 116) Human KLK8 1:2~1:4 Negative Online Inquiry

Background

KLK8 Gene Knockout Cell Lines are specialized cultured cells in which the KLK8 gene has been intentionally disrupted, making these models invaluable for studying the biological roles of KLK8 (Kallikrein-related peptidase 8) in various physiological and pathological processes. KLK8 is known to play a significant role in inflammatory responses, cancer progression, and tissue remodeling, thus providing researchers with critical insights into its function by observing the resultant phenotypic changes associated with its knockout.

Mechanistically, the KLK8 gene knockout is achieved through advanced genome editing techniques such as CRISPR-Cas9, which allows for precise and efficient disruption of the gene, ensuring reliable results in experimental settings. These models can subsequently be utilized to investigate gene interaction networks, signaling pathways, and the effects of KLK8 on cell viability, proliferation, and extracellular matrix composition. This functionality positions KLK8 Gene Knockout Cell Lines as essential tools in both molecular biology research and translational medicine.

In clinical settings, elucidating the role of KLK8 can facilitate the development of targeted therapies for diseases where this gene is implicated, particularly in cancer diagnostics and therapeutics. Compared to conventional cell lines, KLK8 knockout models offer enhanced specificity in studying the KLK8-related biological processes, reducing the background noise often present in wild-type cell lines.

The unique selling points of KLK8 Gene Knockout Cell Lines include optimized gene targeting efficiency, reproducibility across experiments, and a significant reduction in confounding variables, making them a superior choice for researchers aiming to dissect complex biological systems or develop innovative treatment modalities. Their integration into research pipelines can foster groundbreaking discoveries that could ultimately translate into advancements in patient care.

Our company, with its extensive expertise in genetic engineering and cellular models, is committed to providing high-quality biological products that empower researchers and clinicians. The KLK8 Gene Knockout Cell Lines stand as a testament to our dedication to innovation and the advancement of scientific knowledge.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.